- Home
- RCON vs VRCA Comparison
RCON vs VRCA Comparison
Compare RCON & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- VRCA
- Stock Information
- Founded
- RCON 2007
- VRCA 2013
- Country
- RCON China
- VRCA United States
- Employees
- RCON N/A
- VRCA N/A
- Industry
- RCON Oilfield Services/Equipment
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- VRCA Health Care
- Exchange
- RCON Nasdaq
- VRCA Nasdaq
- Market Cap
- RCON 60.5M
- VRCA 54.0M
- IPO Year
- RCON 2009
- VRCA 2018
- Fundamental
- Price
- RCON $2.44
- VRCA $0.69
- Analyst Decision
- RCON
- VRCA Hold
- Analyst Count
- RCON 0
- VRCA 5
- Target Price
- RCON N/A
- VRCA $6.00
- AVG Volume (30 Days)
- RCON 293.7K
- VRCA 632.2K
- Earning Date
- RCON 07-07-2025
- VRCA 08-13-2025
- Dividend Yield
- RCON N/A
- VRCA N/A
- EPS Growth
- RCON N/A
- VRCA N/A
- EPS
- RCON N/A
- VRCA N/A
- Revenue
- RCON $8,996,572.00
- VRCA $7,179,000.00
- Revenue This Year
- RCON N/A
- VRCA $171.87
- Revenue Next Year
- RCON $12.17
- VRCA $71.38
- P/E Ratio
- RCON N/A
- VRCA N/A
- Revenue Growth
- RCON N/A
- VRCA N/A
- 52 Week Low
- RCON $1.35
- VRCA $0.38
- 52 Week High
- RCON $3.70
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- RCON 51.61
- VRCA 58.87
- Support Level
- RCON $2.38
- VRCA $0.52
- Resistance Level
- RCON $2.75
- VRCA $0.67
- Average True Range (ATR)
- RCON 0.32
- VRCA 0.06
- MACD
- RCON -0.02
- VRCA 0.00
- Stochastic Oscillator
- RCON 44.44
- VRCA 71.58
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.